MRI Preclinical Imaging

The Pre-Clinical MR Imaging Facility provides heteronuclear magnetic resonance imaging/spectroscopy (MRI/MRS) expertise and facilities to aid investigators in designing, implementing and analyzing their image based research. MRI is a non-invasive, non-destructive technique which does not use ionizing radiation. Currently, it is the best modality available for the in vivo study of soft tissue lesions. The 4.7 T high field MR Imaging scanner yields data sets with in-plane resolutions < 50 - 100 µM2 and can provide both anatomical and physiologic information related to metabolic activity. MRS yields quantitative concentrations of specific metabolites as a function of time.
The 4.7 Tesla MR has recently been installed at RPCI, in collaboration with the University at Buffalo, to develop multidisciplinary imaging based technologies for therapeutic assessments, diagnosis and monitoring of cancer progression, non-invasive tumor characterization, molecular and cellular biology assessments, developing and assessing multimodality contrast enhancing agents, quality assurance testing of medical devices, development of minimally invasive therapies, and for basic science studies of solid state/semi-solid state/porous media samples.The 4.7 Tesla MR scanner is the first of its kind within a 200-mile radius of Buffalo and should meet the diverse scientific needs of investigators at RPCI and the University at Buffalo, and attract users from the community at-large.

URL: http://www.roswellpark.org/document_1217_409.html

Location:
Roswell Park Cancer Institute
4.7 T High Field Small Bore Research MR scanner: Cancer Cell Center - Ground Floor, Room C164
1.5 T Clinical MR scanner: Department Diagnostic Imaging, MRI Suite, Hospital - Second Floor

Director:
Dr. Richard Mazurchuk
T: [716] 845-5839
F: [716] 845-1764
El: richard.mazurchuk@roswellpark.org

Operator:
Joe Spernyak
T: [716] 845-1551
F: [716] 845-1764
E: joseph.spernyak@roswellpark.org